نتائج البحث - "Anke K. Bergmann"

1

Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study

المساهمون: Pediatrics, Boer, J, Valsecchi, M, Hormann, F, Antic, Z, Zaliova, M, Schwab, C, Cazzaniga, G, Arfeuille, C, Cave, H, Attarbaschi, A, Strehl, S, Escherich, G, Imamura, T, Ohki, K, Gruber, T, Sutton, R, Pastorczak, A, Lammens, T, Lambert, F, Li, C, Carrillo de Santa Pau, E, Hoffmann, S, Moricke, A, Harrison, C, Den Boer, M, De Lorenzo, P, Stam, R, Bergmann, A, Pieters, R

المصدر: Leukemia, 35(10), 2978-2982. Nature Publishing Group
LEUKEMIA
Leukemia

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f60375d46a4d2047696331c40089fb74Test
https://pure.eur.nl/en/publications/6f593ae5-e308-40c5-b120-ffc09327c080Test

2

Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol

المؤلفون: Marie Stelter, Martin Zimmermann, Marcel Tauscher, Mareike Jung, Brigitte Schlegelberger, Gunnar Cario, Martin Schrappe, Anke K. Bergmann, Winfried Hofmann, Julia Alten, Maximilian Schieck, Martin Stanulla, Anja Möricke, Doris Steinemann, Jana Lentes

المصدر: Genes, Chromosomes & Cancer

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Mutation, Missense, acute lymphoblastic leukemia, AIEOP‐BFM ALL, Biology, B‐cell precursor ALL, pediatric acute lymphoblastic leukemia, 03 medical and health sciences, symbols.namesake, 0302 clinical medicine, Gene Frequency, CDKN2A, immune system diseases, White blood cell, Internal medicine, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Genetics, medicine, Biomarkers, Tumor, Asparaginase, Humans, Clinical significance, Copy-number variation, Genotyping, Cyclophosphamide, Sanger sequencing, PAX5, Mercaptopurine, Brief Report, Daunorubicin, Cytarabine, PAX5 Transcription Factor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, ETV6, medicine.anatomical_structure, Methotrexate, Vincristine, 030220 oncology & carcinogenesis, Cohort, symbols, Prednisone, Brief Reports

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b64e08efc8615530b54641186bc674cTest
https://pubmed.ncbi.nlm.nih.gov/32592278Test

3

Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia

المساهمون: Schieck, M, Lentes, J, Thomay, K, Hofmann, W, Behrens, Y, Hagedorn, M, Ebersold, J, Davenport, C, Fazio, G, Moricke, A, Buchmann, S, Alten, J, Cario, G, Schrappe, M, Bergmann, A, Stanulla, M, Steinemann, D, Schlegelberger, B, Cazzaniga, G, Gohring, G

المصدر: Annals of Hematology

مصطلحات موضوعية: 0301 basic medicine, Oncology, Abnormal Karyotype, Acute lymphoblastic leukemia, Workflow, 0302 clinical medicine, Risk Factors, Antineoplastic Combined Chemotherapy Protocols, Prospective Studies, RNA, Neoplasm, Diagnostics, In Situ Hybridization, Fluorescence, Comparative Genomic Hybridization, biology, Mercaptopurine, Cytarabine, RNA sequencing, Hematology, General Medicine, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasm Proteins, KMT2A, Vincristine, 030220 oncology & carcinogenesis, Original Article, SNP array, Fusion transcript, Human, medicine.medical_specialty, Neoplasm Protein, 03 medical and health sciences, Ikaros Transcription Factor, Internal medicine, medicine, Humans, Asparaginase, Diagnostic, RNA, Messenger, Gene, Cyclophosphamide, Risk stratification, IKZF1plu, Antineoplastic Combined Chemotherapy Protocol, business.industry, Sequence Analysis, RNA, Risk Factor, Daunorubicin, RNA, IKZF1plus, Prospective Studie, 030104 developmental biology, Methotrexate, Genetic marker, biology.protein, Hypodiploidy, Prednisone, business, Transcriptome, Comparative genomic hybridization, Genes, Neoplasm

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::822c7b862be227266e539f5f390bbe29Test
http://hdl.handle.net/10281/272323Test

4

Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols

المساهمون: Cario, G, Leoni, V, Conter, V, Attarbaschi, A, Zaliova, M, Sramkova, L, Cazzaniga, G, Fazio, G, Sutton, R, Elitzur, S, Izraeli, S, Lauten, M, Locatelli, F, Basso, G, Buldini, B, Bergmann, A, Lentes, J, Steinemann, D, Göhring, G, Schlegelberger, B, Haas, O, Schewe, D, Buchmann, S, Moericke, A, White, D, Revesz, T, Stanulla, M, Mann, G, Bodmer, N, Arad-Cohen, N, Zuna, J, Valsecchi, M, Zimmermann, M, Schrappe, M, Biondi, A

المصدر: Haematologica

مصطلحات موضوعية: Oncology, medicine.medical_specialty, ABL-class fusion, medicine.drug_class, medicine.medical_treatment, Fusion Proteins, bcr-abl, antineoplastic combined chemotherapy protocols, B-lymphocytes, child, Hematopoietic stem cell transplantation, Tyrosine-kinase inhibitor, Recurrence, Internal medicine, hemic and lymphatic diseases, medicine, Humans, Cumulative incidence, Pediatric Acute Lymphoblastic Leukemia, Child, Chemotherapy, B-Lymphocytes, ABL, business.industry, Hematology, Articles, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Acute Lymphoblastic Leukemia, Prognosis, Tyrosin Kinase Inhibitors, Minimal residual disease, Transplantation, Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA, Stem cell, business, ALL